How to (legally) make psychedelic medicine: CEO of Psygen, Danny Motyka

30:53
 
Share
 

Manage episode 285798791 series 2738732
By Greg Kubin & Matias Serebrinsky, Greg Kubin, and Matias Serebrinsky. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Today's episode features Danny Motyka, founder of Psygen, a Canadian manufacturer of psychedelics, like MDMA, LSD, DMT, and synthetic psilocybin.

Psygen makes pharmaceutical grade psychedelic medicines for clinical research and therapeutic applications. They have a license to be one of the first manufacturing facilities dedicated to the synthesis of psychedelic medicine.

In this episode, we discuss:

  • Behind the scenes of Psygen’s manufacturing process
  • Natural vs Synthetic psychedelics
  • Navigating regulations for manufacturing Schedule 1 substances

Links to topics discussed in this episode:

GMP
Dr. Peter van der Heyden
COMP360
Entourage Effect
Health Canada
Nick Sand - Orange Sunshine
MDMA, LSD, 5-MeO-DMT, Ibogaine, Psilocybin
Entheon Biomedical
MAPS
2C-B
Read the transcript here.
Watch episode 6 on YouTube.
Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin
Produced by Jonathan Davis & Zack Frank
Marketing by DaisyMae VanValkenburgh

Find us at businesstrip.fm
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional music by Crystals by Xylo-Ziko, Obscure Train by Revolution Void, Love Chances by Makaih Beats, and Kleptotonic Swing by Tri-Tachyon

20 episodes